Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1Gastrointestinal 1Endocrine 1

Conditions

Thyroid Carcinoma, Anaplastic 2Sarcoma, Synovial 2Sarcoma, Endometrial Stromal 2Sarcoma 2Pheochromocytoma 2Ovarian Neoplasms 2Neurofibrosarcoma 2Neoplasm Metastasis 2Malignant mesenchymal tumor 2Liposarcoma 2Leiomyosarcoma 2Kidney Neoplasms 2Histiocytoma, Malignant Fibrous 2Hemangiosarcoma 2Hemangiopericytoma, Malignant 2Head and Neck Neoplasms 2Fibrosarcoma 2Endometrial Neoplasms 2Sarcoma, Alveolar Soft Part 1Rhabdomyosarcoma 1Pancreatic Neoplasms 1Neuroendocrine Tumors 1Neuroectodermal Tumors, Primitive 1Neoplasms 1Gastro-enteropancreatic neuroendocrine tumor 1Carcinoma, Islet Cell 1Adrenocortical Carcinoma 1

Interventions

Everolimus 5Octreotide 4Leucovorin 3Capecitabine 3vatalanib 2Trastuzumab 2Temozolomide 2Oxaliplatin 2Melphalan 2Fluorouracil 2Biological Therapy 2Bevacizumab 2tipifarnib 1temsirolimus 1romidepsin 1regorafenib 1pentetreotide 1motesanib diphosphate 1folfirinox 1cixutumumab 1batifiban 1antineoplaston AS 2-1 1antineoplaston A10 1Vinorelbine 1Thalidomide 1Streptozocin 1Sorafenib 1Sirolimus 1Irinotecan 1Interleukin-12 Subunit p35 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Islet Cell × Filgrastim × Endocrine × Clear all
NCT03042780 2020-11-27

FOLFIRINOX in Metastatic High Grade Gastroenteropancreatic Neuroendocrine Carcinomas

H. Lee Moffitt Cancer Center and Research Institute

Phase 2 Terminated
2 enrolled 6 charts
EndocrineGastrointestinalNET

Gastro-enteropancreatic neuroendocrine tumor, Neoplasm Metastasis, Pancreatic Neoplasms, Carcinoma, Islet Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡